Journal:
:hepatitis monthly
0
giulia malaguarnera department of clinical and molecular biomedicine, section of pharmacology and biochemistry, university of catania, catania, italy
manuela pennisi department of neurosciences, university of catania, catania, italy
caterina gagliano the great senescence research center, university of catania, catania, italy
marco vacante the great senescence research center, university of catania, catania, italy
michele malaguarnera department of clinical and molecular biomedicine, section of pharmacology and biochemistry, university of catania, catania, italy; the great senescence research center, university of catania, catania, italy; the great senescence research center, university of catania, catania, italy. tel: +39-957262008, fax: +39-957262011
salvatore salomone department of clinical and molecular biomedicine, section of pharmacology and biochemistry, university of catania, catania, italy
conclusions office workers with chronic hepatitis c, treated with pegylated-interferon-α2b plus ribavirin, had work performance loss. in subjects treated with acetyl-l-carnitine supplementation we observed increased daily activity and reduced presenteeism and fatigue. acetyl-l-carnitinegroup had a smaller reduction of productivity comparing to placebo group. results significant difference were ...